This test is most useful if any of these apply to you.
Almost all of your body's potassium sits inside cells. RBC potassium measures its concentration inside red blood cells, which researchers have studied as a possible clue to potassium balance and blood pressure. The central limitation is that red-cell potassium concentration hasn't been validated as a reliable measure of potassium stores throughout your body.
Some clinical laboratories offer this measurement, but its use for detecting hidden depletion or guiding preventive treatment remains exploratory. Studies haven't established that screening with it, repeatedly tracking it, or treating toward a particular result improves health.
Red cells keep potassium much more concentrated than the surrounding plasma. Proteins in their membranes move potassium into the cells and sodium out. Food supplies potassium, while your kidneys regulate how much leaves your body. Changes in potassium distribution between cells and the surrounding fluid can occur without an equivalent change in total body stores.
This test uses a whole-blood specimen and reports a red-cell potassium concentration in mmol/L. A routine potassium measurement performed on whole blood usually measures potassium in the fluid surrounding intact cells. Sharing a specimen type doesn't make those measurements equivalent.
The assay method isn't specified for this test. Published research has used different preparation and measurement techniques, and those techniques have produced markedly different values in healthy people. Numerical results from those studies shouldn't be treated as interchangeable with your laboratory result.
The Gubbio Population Study examined 1,805 Italian adults. Men with higher red-cell potassium had lower blood pressure and a lower prevalence of hypertension after adjustment for other measured factors. The association appeared stronger in older men. There wasn't a statistically clear relationship between red-cell potassium and blood pressure in women.
A smaller study found lower intracellular potassium in red cells from people with hypertension or type 2 diabetes. It used a research magnetic-resonance technique, so its numerical values cannot be assumed to match this test. These were comparisons between people at one point in time. They don't establish that increasing your red-cell potassium would lower your blood pressure.
A normal serum potassium result can coexist with depleted body stores. That observation prompted early investigations of red-cell potassium. A 1979 report involving 90 older patients proposed it as an indicator of depletion and described weakness, confusion, impaired glucose tolerance, and increased sensitivity to digitalis among affected patients. A 1984 report described 17 older patients with normal serum potassium, low red-cell potassium, and ECG changes that resolved with potassium replacement. A 1987 survey of 381 older people found low red-cell potassium in about 20%, compared with about 2% for low plasma potassium. None of these were controlled studies.
Other studies challenged the assumption that red cells represent the rest of the body. Research in untreated hypertension found no correlation between red-cell potassium and the assessment based on whole-body potassium measurements. In 93 surgical patients, red-cell potassium didn't correlate with potassium in muscle samples. Among 231 people with low plasma potassium, red-cell potassium changed little unless plasma potassium was very low. A low red-cell concentration therefore doesn't establish a whole-body shortage, and a reassuring result cannot exclude one.
Concentration also differs from total amount. It depends on how much potassium is present relative to the volume or water content of the cells being examined. Your red cells can change independently of the much larger potassium supply in muscle.
Large outcome studies have examined serum potassium and dietary potassium intake. A pooled analysis involving more than 1.2 million people linked both low and high serum potassium with higher mortality. Studies of dietary intake have most consistently linked higher intake with lower stroke risk; links with total cardiovascular disease and coronary disease are weaker. These findings concern different measurements and don't establish a desirable red-cell potassium concentration.
The strongest outcome evidence comes from POTCAST, a 2025 randomized trial in people with implanted defibrillators. Raising plasma potassium toward the high end of the normal range reduced a combined outcome of serious heart-rhythm events, hospitalization for heart failure or arrhythmia, and death. The treatment was guided by plasma potassium. RBC potassium played no part.
The association between higher red-cell potassium and lower blood pressure in some studies doesn't mean that higher is always better. There is no established red-cell target for preventing heart attacks, strokes, or premature death.
A 1966 study included 142 healthy adults, but its repeated potassium measurements came from only six participants. Differences between those people exceeded their within-person variation. That small observation doesn't establish how large a change must be to matter clinically or whether routine monitoring improves decisions.
A personal trend may document a change in this measurement. It cannot establish that body stores have improved or that an intervention has reduced your health risks. An individual before-and-after comparison also cannot fill the gap left by a missing treatment trial.
RBC Potassium is best interpreted alongside these tests.